Class I — Serious Health Hazard

Serious health hazard — there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.

ANGIOGUARD RX / XP Emboli Capture Guidewire System Recalled by Cordis US Corp Due to There is a potential for separation of the...

Date: March 24, 2023
Company: Cordis US Corp
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Cordis US Corp directly.

Affected Products

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 401814RMC

Quantity: 283 units

Why Was This Recalled?

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

Where Was This Sold?

Worldwide distribution.

About Cordis US Corp

Cordis US Corp has 22 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report